Oncotarget Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model There are more than 13,000 new cases of malignant brain tumors diagnosed each year... read more June 4, 2025
Oncotarget Engineered Proteins Show Promise in Stopping Glioblastoma Invasion The results demonstrated that the minimal TIMP variants, mTC1, and mTC3, effectively inhibit MMP activity... read more May 21, 2025
Oncotarget New Drug May Boost Effectiveness of Glioblastoma Treatment In a new study, researchers investigated the activity of gartisertib, a potent ATR inhibitor, alone... read more January 25, 2024
Oncotarget Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy... read more May 11, 2023
Oncotarget Researchers Identify New Drug Candidates to Treat DLST+ Tumors The increased expression of DLST has recently been associated with increased tumor aggression and a... read more January 19, 2023
Oncotarget Behind the Study: Extending Survival in Glioma Models Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more May 10, 2021
Oncotarget Behind the Study: Critical Role STAT3 Plays in Glioma-initiating Cells The head chair of pathology and a graduate research assistant from the University of Tennessee... read more February 8, 2021